NCT06086873View on ClinicalTrials.gov

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA

NARecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Dental Implant
Interventions
DEVICE

Implant Type

"Patients enrolled in the study will be allocated to one of three implant groups:~* Group 1: NGA Implant (NobelActive TiUltraNP, Nobel Biocare AG, Switzerland)~* Group 2: BLX implant (BLX) modSLA Surface (BLX, SLActive, Roxolid, Institut Straumann AG, Switzerland)~* Group 3: TLX implant (TLX) modSLA Surface (TLX, SLActive, Roxolid, Institut Straumann AG, Switzerland)."

Trial Locations (1)

E1 1BB

RECRUITING

Royal London Dental Institute, London

All Listed Sponsors
collaborator

Virginia Commonwealth University

OTHER

lead

Barts & The London NHS Trust

OTHER